{"id":3939,"date":"2021-06-12T09:32:59","date_gmt":"2021-06-12T01:32:59","guid":{"rendered":"http:\/\/web.csh.org.tw\/web\/cshmagazine\/?p=3939"},"modified":"2021-06-16T09:41:16","modified_gmt":"2021-06-16T01:41:16","slug":"%e5%85%8d%e7%96%ab%e5%89%8d%e5%93%a8%e7%ab%99%e6%8a%91%e5%88%b6%e5%8a%91%e5%b0%8d%e4%b8%89%e9%99%b0%e4%b9%b3%e7%99%8c%e6%b2%bb%e7%99%82%e7%9a%84%e6%96%b0%e9%80%b2%e5%b1%95","status":"publish","type":"post","link":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/?p=3939","title":{"rendered":"\u514d\u75ab\u524d\u54e8\u7ad9\u6291\u5236\u5291\u5c0d\u4e09\u9670\u4e73\u764c\u6cbb\u7642\u7684\u65b0\u9032\u5c55"},"content":{"rendered":"\n<p style=\"text-align:right\">\u6587\/\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u4e73\u623f\u7532\u72c0\u817a\u5916\u79d1\u00a0 <strong>\u59da\u5fe0\u747e<\/strong> \u4e3b\u4efb<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"alignleft is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/web.csh.org.tw\/web\/cshmagazine\/wp-content\/uploads\/2021\/06\/11061245-968x1024.jpg\" alt=\"\" class=\"wp-image-3940\" width=\"252\" height=\"267\"\/><figcaption>\u4e73\u623f\u7532\u72c0\u817a\u5916\u79d1\u00a0 \u00a0\u59da\u5fe0\u747e\u91ab\u5e2b<\/figcaption><\/figure><\/div>\n\n\n\n<p>\u8fd1\u5e74\u764c\u75c7\u6cbb\u7642\u6700\u7576\u7d05\u7684\u8a71\u984c\u83ab\u904e\u65bc\u514d\u75ab\u6cbb\u7642\u3002\u81ea\u5f9e\u514d\u75ab\u6cbb\u7642\u7a81\u7834\u4e86\u9ed1\u8272\u7d20\u764c\u7684\u6cbb\u7642\u56f0\u5883\u5f8c\uff0c\u79d1\u5b78\u5bb6\u7a4d\u6975\u5730\u5617\u8a66\u8457\u5c07\u514d\u75ab\u6cbb\u7642\u904b\u7528\u5728\u5176\u4ed6\u7684\u764c\u75c7\uff0c\u671f\u76fc\u4e5f\u80fd\u70ba\u5176\u4ed6\u7684\u75c5\u53cb\u5e36\u4f86\u798f\u97f3\uff0c\u4e73\u764c\u7576\u7136\u4e5f\u4e0d\u4f8b\u5916\u3002<\/p>\n\n\n\n<p>\u8fd1\u671f\u6700\u71b1\u9580\u7684\u514d\u75ab\u524d\u54e8\u7ad9\u6291\u5236\u5291(check point inhibitor)\uff0c\u76ee\u524d\u7372\u5f97\u7f8e\u570bFDA\u6838\u53ef\u901a\u904e\u7684\u85e5\u7269\u5305\u62ec\u5169\u5927\u985e\uff1a(1) cytotoxic T-lymphocyte antigen 4 (CTLA-4)\u6291\u5236\u5291\u3001\u53ca(2) programmed death-1(PD-1)\/ programmed death ligant-1 PD-L1\u6291\u5236\u5291\u3002<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>(1) CTLA-4\u6291\u5236\u5291\uff1aCTLA-4\u5728T\u7d30\u80de\u6d3b\u5316\u7684\u904e\u7a0b\u4e2d\u6703\u77ed\u66ab\u7684\u6d3b\u6027\u4e0a\u5347\uff0c\u548c\u4f4d\u65bc\u6297\u539f\u5448\u73fe\u7d30\u80de(APC)\u4e0a\u7684B7\u53d7\u9ad4\u63a5\u5408\u7684\u6642\u5019\uff0c\u7522\u751f\u5c0dT\u7d30\u80de\u6291\u5236\u7684\u8a0a\u865f\uff0c\u907f\u514dT\u7d30\u80de\u53d7\u5230\u904e\u5ea6\u6d3b\u5316\uff0c\u5f15\u767c\u904e\u5ea6\u514d\u75ab\u53cd\u61c9\uff0c\u9019\u5728\u6b63\u5e38\u4eba\u9ad4\u662f\u4e00\u500b\u4fdd\u8b77\u6a5f\u5236\u3002\u4f46\u5728\u816b\u7624\u75c5\u60a3\uff0cCTLA-4\u7684\u8868\u73fe\u6291\u5236\u4e86T\u7d30\u80de\u7684\u6d3b\u5316\u800c\u5931\u53bb\u4e86\u6bd2\u6bba\u764c\u7d30\u80de\u7684\u80fd\u529b\u3002\u56e0\u6b64\uff0c\u4f7f\u7528CTLA-4\u6297\u9ad4\u53ef\u4ee5\u963b\u65b7CTLA-4\u5c0dT\u7d30\u80de\u9020\u6210\u7684\u6291\u5236\u8a0a\u865f\uff0c\u6062\u5fa9T\u7d30\u80de\u6bd2\u6bba\u764c\u7d30\u80de\u7684\u80fd\u529b\u3002<\/li><\/ul>\n\n\n\n<ul class=\"wp-block-list\"><li>(2) PD-1\/PD-L1\u6291\u5236\u5291\uff1aPD-1\u662fT\u7d30\u80de\u4e0a\u53e6\u4e00\u500b\u6291\u5236\u8a0a\u865f\u7684\u63a5\u53d7\u9ad4\uff0c\u5176\u529f\u80fd\u662f\u5728\u9577\u671f\u6297\u539f\u523a\u6fc0\u7684\u60c5\u5f62\u4e0b(\u4f8b\u5982\u816b\u7624\u6216\u662f\u6162\u6027\u75c5\u6bd2\u611f\u67d3)\uff0c\u6291\u5236T\u7d30\u80de\u7684\u6d3b\u5316\u907f\u514d\u904e\u5ea6\u7684\u514d\u75ab\u53cd\u61c9\u3002\u764c\u7d30\u80de\u4e5f\u6703\u5229\u7528\u9019\u500b\u6a5f\u5236\u50b3\u905e\u6291\u5236\u8a0a\u865f\uff0c\u85c9\u7531\u8868\u73fePD-L1\uff0c\u4f86\u6291\u5236\u6bd2\u6bba\u578bT\u7d30\u80de\u7684\u6d3b\u5316\uff0c\u9032\u800c\u9054\u5230\u8ff4\u907f\u514d\u75ab\u653b\u64ca\u7684\u76ee\u7684\u3002<\/li><\/ul>\n\n\n\n<p>\u9019\u4e9b\u6a19\u9776\u85e5\u7269(\u76ee\u524d\u90fd\u662f\u55ae\u682a\u6297\u9ad4)\u80fd\u548c\u6aa2\u67e5\u54e8\u8a0a\u865f\u5206\u5b50\u7d50\u5408\uff0c\u8b93T\u7d30\u80de\u300c\u715e\u8eca\u300d\u7684\u6307\u4ee4\u7121\u6cd5\u50b3\u905e\u3002\u9019\u6a23\u4e00\u4f86\uff0cT\u7d30\u80de\u6bb2\u6ec5\u764c\u7d30\u80de\u7684\u4efb\u52d9\u4fbf\u53ef\u9806\u5229\u9032\u884c\u3002\u76ee\u524d\u5728\u8f49\u79fb\u6027\u4e09\u9670\u6027\u4e73\u764c\u662f\u4ee5\nAtezolizumab\u4ee5pembrolizumab\u5169\u7a2e\u85e5\u7269\u7684\u81e8\u5e8a\u8a3c\u64da\u6700\u70ba\u5145\u4efd\uff0c\u53ef\u4ee5\u6709\u610f\u7fa9\u7684\u5ef6\u9577\u75c5\u4eba\u7684\u751f\u5b58\u671f\u3002<\/p>\n\n\n\n<p>\u76ee\u524d\u5169\u500b\u6700\u65b0\u7684\u81e8\u5e8a\u7814\u7a76\u5831\u544a( Impassion 130\u53ca keynote 355)\u6307\u51faAtezolizumab (anti-PD-L1\nAb)\u5728\u75c5\u7406\u6aa2\u9ad4\u81f3\u5c11\u8868\u73fe1%\u4ee5\u4e0aPD-L1\u7684\u8f49\u79fb\u4e09\u9670\u6027\u4e73\u764c\u75c5\u4eba\uff0c\u5408\u4f75\u5316\u7642\u85e5\u7269(nabpaclitaxel)\uff0c\u53ef\u4ee5\u5f97\u523025\u500b\u6708\u7684\u5e73\u5747\u5b58\u6d3b\u6642\u9593(\u5c0d\u7167\u7d44\u70ba18\u500b\u6708)\u3002\u800cpembrolizumab (anti-PD-1\nAb)\u9019\u500b\u85e5\u7269\u5728PD-L1(+)\u8f49\u79fb\u6027\u4e09\u9670\u6027\u4e73\u764c\u60a3\u8005\uff0c\u5408\u4f75\u5316\u7642\u85e5\u7269\u4e5f\u53ef\u4ee5\u5f97\u523025\u500b\u6708\u7684\u5e73\u5747\u5b58\u6d3b\u6642\u9593(\u5c0d\u7167\u7d44\u70ba15.5\u500b\u6708) \u3002<\/p>\n\n\n\n<p>\u5118\u7ba1\u76ee\u524d\u4e73\u764c\u514d\u75ab\u6cbb\u7642\u65b9\u9762\u7684\u7814\u7a76\u7d50\u679c\u4e26\u4e0d\u5982\u9ed1\u8272\u7d20\u764c\u9192\u76ee\uff0c\u7136\u800c\u5728\u8a31\u591a\u7684\u79d1\u5b78\u5bb6\u6295\u5165\u7814\u7a76\u4e0b\uff0c\u5e0c\u5180\u672a\u4f86\u80fd\u6709\u66f4\u591a\u7684\u7dda\u7d22\uff0c\u8b93\u6211\u5011\u5c0d\u5982\u4f55\u559a\u9192\u9ad4\u5167\u7684\u514d\u75ab\u7d30\u80de\u4f86\u6d88\u6ec5\u764c\u7d30\u80de\u6709\u66f4\u591a\u8a8d\u8b58\uff0c\u8b93\u514d\u75ab\u6cbb\u7642\u5728\u4e73\u764c\u7684\u61c9\u7528\u4e0a\u6709\u66f4\u597d\u7684\u9032\u5c55\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u6587\/\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u4e73\u623f\u7532\u72c0\u817a\u5916\u79d1\u00a0 \u59da\u5fe0\u747e \u4e3b\u4efb \u8fd1\u5e74\u764c\u75c7\u6cbb\u7642\u6700\u7576\u7d05\u7684\u8a71\u984c\u83ab\u904e\u65bc\u514d\u75ab\u6cbb\u7642\u3002\u81ea\u5f9e\u514d\u75ab\u6cbb\u7642 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[123,124],"class_list":["post-3939","post","type-post","status-publish","format-standard","hentry","category-19","tag-123","tag-124"],"_links":{"self":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts\/3939"}],"collection":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3939"}],"version-history":[{"count":1,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts\/3939\/revisions"}],"predecessor-version":[{"id":3941,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=\/wp\/v2\/posts\/3939\/revisions\/3941"}],"wp:attachment":[{"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/cshmagazine\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}